vs
AerSale Corp（ASLE）与RHYTHM PHARMACEUTICALS, INC.（RYTM）财务数据对比。点击上方公司名可切换其他公司
AerSale Corp的季度营收约是RHYTHM PHARMACEUTICALS, INC.的1.6倍（$90.9M vs $57.3M），AerSale Corp净利率更高（5.9% vs -83.0%，领先88.9%），RHYTHM PHARMACEUTICALS, INC.同比增速更快（36.9% vs -4.0%），过去两年RHYTHM PHARMACEUTICALS, INC.的营收复合增速更高（48.5% vs 0.2%）
AerSale Corp总部位于美国佛罗里达州多拉市，是一家面向航空领域的全球供应商，主要为客运及货运航空公司、政府机构、跨国整机制造商与独立维修机构提供商用喷气飞机二手整机、发动机、航空耗材，并提供航空工程服务，同时该公司也是飞机机队回收协会的成员企业。
Rhythm Pharmaceuticals是一家专注于罕见病领域的生物制药企业，主要开发和商业化针对罕见遗传性肥胖症的靶向疗法，覆盖POMC缺陷、LEPR缺陷、巴德-毕德氏综合征等适应症，服务北美、欧洲地区缺少有效治疗方案的患者群体。
ASLE vs RYTM — 直观对比
营收规模更大
ASLE
是对方的1.6倍
$57.3M
营收增速更快
RYTM
高出40.9%
-4.0%
净利率更高
ASLE
高出88.9%
-83.0%
两年增速更快
RYTM
近两年复合增速
0.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $90.9M | $57.3M |
| 净利润 | $5.4M | $-47.5M |
| 毛利率 | 34.1% | 91.6% |
| 营业利润率 | 7.8% | -82.2% |
| 净利率 | 5.9% | -83.0% |
| 营收同比 | -4.0% | 36.9% |
| 净利润同比 | 99.7% | -9.6% |
| 每股收益（稀释后） | $0.10 | $-0.73 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASLERYTM
| Q4 25 | $90.9M | $57.3M | ||
| Q3 25 | $71.2M | $51.3M | ||
| Q2 25 | $107.4M | $48.5M | ||
| Q1 25 | $65.8M | $32.7M | ||
| Q4 24 | $94.7M | $41.8M | ||
| Q3 24 | $82.7M | $33.3M | ||
| Q2 24 | $77.1M | $29.1M | ||
| Q1 24 | $90.5M | $26.0M |
净利润ASLERYTM
| Q4 25 | $5.4M | $-47.5M | ||
| Q3 25 | $-120.0K | $-52.9M | ||
| Q2 25 | $8.6M | $-46.6M | ||
| Q1 25 | $-5.3M | $-49.5M | ||
| Q4 24 | $2.7M | $-43.3M | ||
| Q3 24 | $509.0K | $-43.6M | ||
| Q2 24 | $-3.6M | $-32.3M | ||
| Q1 24 | $6.3M | $-141.4M |
毛利率ASLERYTM
| Q4 25 | 34.1% | 91.6% | ||
| Q3 25 | 30.2% | 89.3% | ||
| Q2 25 | 32.9% | 88.6% | ||
| Q1 25 | 27.3% | 88.8% | ||
| Q4 24 | 31.4% | 90.9% | ||
| Q3 24 | 28.6% | 88.5% | ||
| Q2 24 | 28.2% | 89.9% | ||
| Q1 24 | 31.8% | 89.2% |
营业利润率ASLERYTM
| Q4 25 | 7.8% | -82.2% | ||
| Q3 25 | 4.0% | -102.6% | ||
| Q2 25 | 11.7% | -93.4% | ||
| Q1 25 | -10.1% | -143.7% | ||
| Q4 24 | 5.2% | -98.6% | ||
| Q3 24 | 2.4% | -132.0% | ||
| Q2 24 | -2.4% | -139.2% | ||
| Q1 24 | 5.2% | -538.7% |
净利率ASLERYTM
| Q4 25 | 5.9% | -83.0% | ||
| Q3 25 | -0.2% | -103.1% | ||
| Q2 25 | 8.0% | -96.1% | ||
| Q1 25 | -8.0% | -151.4% | ||
| Q4 24 | 2.9% | -103.6% | ||
| Q3 24 | 0.6% | -131.2% | ||
| Q2 24 | -4.7% | -110.9% | ||
| Q1 24 | 6.9% | -544.4% |
每股收益（稀释后）ASLERYTM
| Q4 25 | $0.10 | $-0.73 | ||
| Q3 25 | $0.00 | $-0.82 | ||
| Q2 25 | $0.18 | $-0.75 | ||
| Q1 25 | $-0.10 | $-0.81 | ||
| Q4 24 | $0.05 | $-0.71 | ||
| Q3 24 | $0.01 | $-0.73 | ||
| Q2 24 | $-0.07 | $-0.55 | ||
| Q1 24 | $0.12 | $-2.35 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.4M | $388.9M |
| 总债务越低越好 | $1.3M | — |
| 股东权益账面价值 | $424.4M | $139.1M |
| 总资产 | $640.5M | $480.2M |
| 负债/权益比越低杠杆越低 | 0.00× | — |
8季度趋势，按日历期对齐
现金及短期投资ASLERYTM
| Q4 25 | $4.4M | $388.9M | ||
| Q3 25 | $5.3M | $416.1M | ||
| Q2 25 | $5.7M | $291.0M | ||
| Q1 25 | $4.7M | $314.5M | ||
| Q4 24 | $4.7M | $320.6M | ||
| Q3 24 | $9.8M | $298.4M | ||
| Q2 24 | $4.3M | $319.1M | ||
| Q1 24 | $2.6M | $201.2M |
总债务ASLERYTM
| Q4 25 | $1.3M | — | ||
| Q3 25 | $1.5M | — | ||
| Q2 25 | $907.0K | — | ||
| Q1 25 | $1.1M | — | ||
| Q4 24 | $1.2M | — | ||
| Q3 24 | $376.0K | — | ||
| Q2 24 | $522.0K | — | ||
| Q1 24 | $3.5M | — |
股东权益ASLERYTM
| Q4 25 | $424.4M | $139.1M | ||
| Q3 25 | $417.1M | $148.8M | ||
| Q2 25 | $415.9M | $-11.9M | ||
| Q1 25 | $406.5M | $18.9M | ||
| Q4 24 | $455.6M | $21.7M | ||
| Q3 24 | $451.5M | $11.2M | ||
| Q2 24 | $449.8M | $39.3M | ||
| Q1 24 | $452.0M | $61.6M |
总资产ASLERYTM
| Q4 25 | $640.5M | $480.2M | ||
| Q3 25 | $646.3M | $506.9M | ||
| Q2 25 | $646.7M | $372.7M | ||
| Q1 25 | $646.1M | $386.7M | ||
| Q4 24 | $604.7M | $392.3M | ||
| Q3 24 | $601.5M | $363.6M | ||
| Q2 24 | $598.7M | $381.8M | ||
| Q1 24 | $571.7M | $258.7M |
负债/权益比ASLERYTM
| Q4 25 | 0.00× | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | 0.00× | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | 0.00× | — | ||
| Q1 24 | 0.01× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $11.4M | $-25.4M |
| 自由现金流经营现金流 - 资本支出 | $9.8M | — |
| 自由现金流率自由现金流/营收 | 10.8% | — |
| 资本支出强度资本支出/营收 | 1.7% | — |
| 现金转化率经营现金流/净利润 | 2.11× | — |
| 过去12个月自由现金流最近4个季度 | $-29.1M | — |
8季度趋势，按日历期对齐
经营现金流ASLERYTM
| Q4 25 | $11.4M | $-25.4M | ||
| Q3 25 | $-8.9M | $-26.6M | ||
| Q2 25 | $19.8M | $-23.3M | ||
| Q1 25 | $-45.2M | $-40.4M | ||
| Q4 24 | $37.5M | $-18.8M | ||
| Q3 24 | $10.4M | $-25.2M | ||
| Q2 24 | $-15.3M | $-29.1M | ||
| Q1 24 | $-21.5M | $-40.7M |
自由现金流ASLERYTM
| Q4 25 | $9.8M | — | ||
| Q3 25 | $-9.8M | — | ||
| Q2 25 | $18.6M | — | ||
| Q1 25 | $-47.6M | — | ||
| Q4 24 | $32.3M | — | ||
| Q3 24 | $8.9M | — | ||
| Q2 24 | $-18.9M | — | ||
| Q1 24 | $-25.0M | — |
自由现金流率ASLERYTM
| Q4 25 | 10.8% | — | ||
| Q3 25 | -13.8% | — | ||
| Q2 25 | 17.3% | — | ||
| Q1 25 | -72.4% | — | ||
| Q4 24 | 34.0% | — | ||
| Q3 24 | 10.7% | — | ||
| Q2 24 | -24.6% | — | ||
| Q1 24 | -27.7% | — |
资本支出强度ASLERYTM
| Q4 25 | 1.7% | — | ||
| Q3 25 | 1.3% | — | ||
| Q2 25 | 1.1% | — | ||
| Q1 25 | 3.7% | — | ||
| Q4 24 | 5.6% | — | ||
| Q3 24 | 1.9% | — | ||
| Q2 24 | 4.7% | — | ||
| Q1 24 | 3.9% | — |
现金转化率ASLERYTM
| Q4 25 | 2.11× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 2.31× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 13.89× | — | ||
| Q3 24 | 20.52× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -3.42× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASLE
| Products | $57.8M | 64% |
| Maintenance | $23.2M | 26% |
| Leasing Arrangements | $9.9M | 11% |
RYTM
暂无分部数据
